Jeff Elton, Ph.D., is currently Vice Chairman of ConcertAI and the former founding CEO. ConcertAI, is a global leader in Scientific and Clinical AI Solutions for life sciences companies and healthcare providers, partnered with NVIDIA, Caris Life Sciences, Guardant Health, and others. ConcertAI solutions are used by more than 80 life science companies, 2000 healthcare providers, and 200 clinical research sites, enabling higher precision and performance in clinical trials and more accurate and confident diagnoses and selection of clinical interventions and treatments. ConcertAI’s CancerLinQ initiative is partnered with leading medical societies, such as the American Society of Clinical Oncology (ASCO). Previously, Jeff held executive leadership positions at Accenture, Novartis Institutes for BioMedical Research, and McKinsey. He is Vice Chair of MassBio, co-author of Healthcare Disrupted, and a frequent contributor to peer-reviewed medical publications, industry overviews, and published perspective.